Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
266 results found
2016 ∙ Kraicer-Melamed, H. O'Donnell, S. Quach, C.
The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis
Adults Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2016 ∙ Voysey, M. Sadarangani, M. Clutterbuck, E. Bolgiano, B. Pollard, A. J.
The impact of administration of conjugate vaccines containing cross reacting material on Haemophilus influenzae type b antibody responses in infants: A systematic review and meta-analysis of randomised controlled trials
Newborn Haemophilus influenzae type B Meningococcal disease Pneumococcal disease Administration Efficacy/effectiveness
Rating:
Critically low
2016 ∙ Nicholls, T. R. Leach, A. J. Morris, P. S.
The short-term impact of each primary dose of pneumococcal conjugate vaccine on nasopharyngeal carriage: Systematic review and meta-analyses of randomised controlled trials
Newborn Influenza Pneumococcal disease Streptococcus group B Administration Efficacy/effectiveness
Rating:
Critically low
2016 ∙ Health Council of the Netherlands
11th meeting of the Committee on Vaccination
Agenda & Minutes Europe Netherlands Pneumococcal disease
Download:
2016 ∙ Ole Wichmann, E Hummers-Pradier, T Ledig, STIKO, Cornelius Remschmidt, Thomas Harder, G Falkenhorst, S Glodny, Christian Bogdan
Background paper to the updated pneumococcal vaccination recommendation for older adults in Germany
Background paper Europe Germany Pneumococcal disease
Download:
2016 ∙ CoPI
Recommendation on the Replacement of PCV-10 with PCV-13
Recommendation Africa Mozambique Pneumococcal disease
Download:
2015 ∙ Malerba, V. Costantino, C. Napoli, G. Marchese, V. Casuccio, A. Tabacchi, G. Vitale, F.
Antimeningococcal and antipneumococcal vaccination determinants: a European systematic literature review
Europe Adolescents Adults Older adults Parents/caregivers Meningococcal disease Pneumococcal disease Coverage Acceptance
Rating:
Not applicable
2015 ∙ Vlachopoulos, C. V. Terentes-Printzios, D. G. Aznaouridis, K. A. Pietri, P. G. Stefanadis, C. I.
Association between pneumococcal vaccination and cardiovascular outcomes: A systematic review and meta-analysis of cohort studies
Adults Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2015 ∙ Wu, D. B. C. Chaiyakunapruk, N. Chong, H. Y. Beutels, P.
Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: A review of economic evaluations (2006-2014)
All age groups Pneumococcal disease Economic aspects Administration Coverage
Rating:
Not applicable
2015 ∙ Caya, C. A. Boikos, C. Desai, S. Quach, C.
Dosing regimen of the 23-valent pneumococcal vaccination: A systematic review
All age groups Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
Loading...